Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Grand Brilliance Group Holdings's quarterly market cap
increased
from Mar. 2025 (HK$86.4 Mil) to Sep. 2025 (HK$87.2 Mil) and
increased
from Sep. 2025 (HK$87.2 Mil) to Mar. 2026 (HK$104.8 Mil).
Grand Brilliance Group Holdings's annual market cap
increased
from Mar. 2024 (HK$80.0 Mil) to Mar. 2025 (HK$86.4 Mil) and
increased
from Mar. 2025 (HK$86.4 Mil) to Mar. 2026 (HK$104.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Grand Brilliance Group Holdings's Enterprise Value for Today is HK$49.8 Mil.
Grand Brilliance Group Holdings (HKSE:08372) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Grand Brilliance Group Holdings Market Cap Related Terms
Grand Brilliance Group Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08372 vs MCK, COR, CAH: Market Cap Comparison
For the Medical Distribution subindustry, Grand Brilliance Group Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Brilliance Group Holdings Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Grand Brilliance Group Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Grand Brilliance Group Holdings's Market Cap falls into.
Grand Brilliance Group Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grand Brilliance Group Holdings (HKSE:08372) has a Market Cap of HK$101.6 Mil as of Aug. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Grand Brilliance Group Holdings and its competitors. According to the industry distribution chart, Grand Brilliance Group Holdings ranks #100 out of 122 companies in the Medical Distribution industry, placing it in the top 82%.
Is Grand Brilliance Group Holdings' Market Cap too high?
Grand Brilliance Group Holdings' current Market Cap is HK$101.6 Mil. Based on the distribution chart, Grand Brilliance Group Holdings ranks #100 out of 122 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Grand Brilliance Group Holdings has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Grand Brilliance Group Holdings' Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Grand Brilliance Group Holdings ranks #100 out of 122 companies for Market Cap. This places Grand Brilliance Group Holdings in the lower half of its industry. The industry median Market Cap is 141.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 141.92, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Grand Brilliance Group Holdings and its competitors. For the Medical Distribution industry, the median Market Cap is 141.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Brilliance Group Holdings's current Market Cap is HK$101.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Brilliance Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Grand Brilliance Group Holdings (HKSE:08372) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.12, compared to a current price of HK$0.13 — trading 5.8% above its estimated fair value. The current Market Cap is HK$101.6 Mil. Grand Brilliance Group Holdings' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Grand Brilliance Group Holdings (HKSE:08372), the current Market Cap is HK$101.6 Mil as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grand Brilliance Group Holdings (HKSE:08372) Overvalued in 2026?
Based on GuruFocus' analysis, Grand Brilliance Group Holdings stock appears to be overvalued.
The current stock price of HK$0.13 is trading 5.8% above its estimated GF Value™ of HK$0.12.
GuruFocus considers Grand Brilliance Group Holdings to be Fairly Valued.
Key valuation signals for HKSE:08372:
Market Cap: HK$101.6 Mil
GF Value™: HK$0.12 vs. price of HK$0.13 (5.8% above fair value)
No single metric tells the full story. See the HKSE:08372 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. It serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
66GF Score
Get the complete analysis for HKSE:08372
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08372 has been successfully added to your 
